4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000034
Director sold 8,000 shares at an average $19.60 ($156,769)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fromkin Andrew J. Director | 2025-03-07 | Sale 10b5-1 | −6,616 | $19.52 | $129,144 | 93,297 | D |
| Fromkin Andrew J. Director | 2025-03-07 | Sale 10b5-1 | −1,384 | $19.96 | $27,625 | 91,913 | D |
| Open-market sales · 8,000 sh · avg $19.60 · $156,769 | |||||||
Loading xslF345X05/wk-form4_1741724319.xml…